Sofosbuvir plus Ribavirin for the Treatment of Russian Patients with Chronic HCV Genotype 1 or 3 Infection

被引：0

作者：

Chulanov, Vladimir ^{[1
]}

Zhdanov, Konstantin ^{[2
]}

Kersey, Kathryn ^{[3
]}

Zhu, Yanni ^{[3
]}

Massetto, Benedetta ^{[3
]}

Zhuravel, Sergey ^{[4
]}

Romanova, Svetlana ^{[5
]}

Nurmukhametova, Elena ^{[6
]}

Morozov, Viacheslav ^{[7
]}

Kozhevnikova, Galina ^{[1
]}

Gogova, Larisa ^{[8
]}

Geyvandova, Natalia ^{[9
]}

Gankina, Natalia ^{[10
]}

Chesnokov, Evgenii ^{[11
]}

Burnevich, Eduard Z. ^{[12
]}

Bessonova, Elena ^{[13
]}

Abdurakhmanov, Djamal ^{[14
]}

Brainard, Diana M. ^{[3
]}

McHutchison, John G. ^{[3
]}

Bakulin, Igor G. ^{[15
]}

Isakov, Vasily ^{[16
]}

机构：

[1] Cent Res Inst Epidemiol, Moscow, Russia

[2] SM Kirov Mil Med Acad, St Petersburg, Russia

[3] Gilead Sci Inc, Foster City, CA 94404 USA

[4] Sci Res Inst Emergency Care, Moscow, Russia

[5] Ctr Prevent & Control AIDS & Infect Dis, St Petersburg, Russia

[6] Infect Clin Hosp 1, Moscow, Russia

[7] Med Co Hepatolog LLC, Samara, Russia

[8] Russian Acad Sci, Cent Clin Hosp, Moscow, Russia

[9] Stavropol Reg Clin Ctr Special Med Care, Stavropol, Russia

[10] Krasnoyarsk Reg Ctr Prevent & Control AIDS & Infe, Krasnoyarsk, Russia

[11] Consultat & Diagnost Ctr, Tyumen, Russia

[12] City Clin Hosp 24, Moscow, Russia

[13] Sverdlovsk Reg Clin Hosp 1, Ekaterinburg, Russia

[14] IM Sechenov First Moscow State Med Univ, Moscow, Russia

[15] Moscow Cent Sci Inst Gastroenterol, Moscow, Russia

[16] Russian Acad Med Sci, Inst Nutr, Moscow 109801, Russia

来源：

HEPATOLOGY | 2014年 / 60卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

982

引用

页码：676A / 677A

页数：2

共 50 条

[31] Sofosbuvir plus ribavirin in Asian patients with chronic genotype 2 hepatitisCvirus infection: history of a success?
Saez-Royuela, Federico
Badia, Ester
LIVER INTERNATIONAL, 2016, 36 (08) : 1093 - 1095
[32] Cost-effectiveness of elbasvir/grazoprevir plus sofosbuvir for the treatment of chronic HCV genotype 3 infection in Argentina
Bissio, E.
Nwankwo, C.
Corman, S.
Monsanto, H.
Montes, J. L.
JOURNAL OF HEPATOLOGY, 2018, 68 : S189 - S190
[33] EFFECTIVENESS AND SAFETY OF SOFOSBUVIR AND RIBAVIRIN FOR ELDERLY PATIENTS WITH HCV GENOTYPE 2 INFECTION
Ogawa, E.
Furusyo, N.
Nomura, H.
Yamashita, N.
Dohmen, K.
Kawano, A.
Takahashi, K.
Azuma, K.
Satoh, T.
Nakamuta, M.
Koyanagi, T.
Kotoh, K.
Shimoda, S.
Hayashi, J.
JOURNAL OF HEPATOLOGY, 2016, 64 : S759 - S760
[34] High Efficacy of Treatment with Sofosbuvir+GS-5816 ±Ribavirin for 12 Weeks in Treatment Experienced Patients with Genotype 1 or 3 HCV Infection
Pianko, Stephen
Flamm, Steven L.
Shiffman, Mitchell L.
Kumar, Sonal
Strasser, Simone I.
Dore, Gregory J.
McNally, John
Brainard, Diana M.
Han, Lingling
Doehle, Brian
Mogalian, Erik
McHutchison, John G.
Reddy, K. Rajender
Roberts, Stuart K.
HEPATOLOGY, 2014, 60 : 297A - 298A
[35] All-Oral Therapy With Sofosbuvir Plus Ribavirin For the Treatment of HCV Genotype 1, 2, and 3 Infection in Patients Co-infected With HIV (PHOTON-1)
Sulkowski, Mark S.
Rodriguez-Torres, Maribel
Lalezari, Jacob P.
Fessel, W. Jeffrey
Mounzer, Karam
Shuhart, Margaret C.
Luetkemeyer, Anne
Asmuth, David M.
Gaggar, Anuj
Symonds, William T.
McHutchison, John G.
Naggie, Susanna
Dieterich, Douglas T.
HEPATOLOGY, 2013, 58 : 313A - 314A
[36] Sofosbuvir plus Ribavirin for 12 or 24 Weeks for Patients with HCV Genotype 2 or 3: the VALENCE trial
Zeuzem, Stefan
Dusheiko, Geoffrey M.
Salupere, Riina
Mangia, Alessandra
Flisiak, Robert
Hyland, Robert H.
Illeperuma, Ari
Svarovskaia, Evguenia S.
Brainard, Diana M.
Symonds, William T.
McHutchison, John G.
Weiland, Ola
Reesink, Hendrik W.
Ferenci, Peter
Hezode, Christophe
Esteban, Rafael
HEPATOLOGY, 2013, 58 : 733A - 734A
[37] Sofosbuvir and ribavirin achieves high SVR in patients with genotype 2 or 3 HCV infection who are without treatment options
Pianko, S.
Nelson, D. R.
Gordon, S. C.
Kowdley, K. V.
Yoshida, E. M.
Rodriguez-Torres, M.
Sulkowski, M. S.
Shiffman, M. L.
Lawitz, E.
Everson, G. T.
Bennett, M.
Schiff, E.
Al-Assi, M. T.
Subramanian, G. M.
An, D.
Lin, M.
Mcnally, J.
Brainard, D. M.
Symonds, W. T.
Mchutchison, J. G.
Patel, K.
Feld, J.
Jacobson, I. M.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 164 - 165
[38] High Rates of SVR in Patients with Genotype 1 HCV Infection and Cirrhosis After Treatment with Ledipasvir/Sofosbuvir plus Ribavirin or Ledipasvir/Sofosbuvir+GS-9669 for 8 weeks
Lawitz, Eric
Poordad, Fred
Hyland, Robert H.
Wang, Jing
Pang, Phillip S.
Symonds, William T.
McHutchison, John G.
Membreno, Fernando E.
HEPATOLOGY, 2014, 60 : 1143A - 1143A
[39] Efficacy and Safety of Sofosbuvir Plus Ribavirin Treatment for Patients with Chronic Hepatitis C Genotype 2
Sugimoto, Kayo
Kim, Soo Ki
Kim, Soo Ryang
Kobayashi, Mana
Kato, Airi
Morimoto, Eri
Imoto, Susumu
Kim, Chi Wan
Tanaka, Yasuhito
Kudo, Masatoshi
Yano, Yoshihiko
Hayashi, Yoshitake
DIGESTIVE DISEASES, 2016, 34 (06) : 627 - 631
[40] Effect of Ribavirin on the Safety Profile of Daclatasvir Plus Sofosbuvir for Patients With Chronic HCV Infection Presidential Poster
Sulkowski, Mark
Gardiner, David
Hughes, Eric
Huang, Shu-Pang
Grasela, Dennis
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S169 - S169

← 1 2 3 4 5 →